JUNS Annual EBITDA
-$4.57 M
-$348.30 K-8.26%
01 December 2023
Summary:
As of January 23, 2025, JUNS annual earnings before interest, taxes, depreciation & amortization is -$4.57 million, with the most recent change of -$348.30 thousand (-8.26%) on December 1, 2023. During the last 3 years, it has fallen by -$2.92 million (-178.15%). JUNS annual EBITDA is now -178.15% below its all-time high of -$1.64 million, reached on December 1, 2020.JUNS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JUNS Quarterly EBITDA
-$493.52 K
-$862.92 K-233.60%
30 September 2024
Summary:
As of January 23, 2025, JUNS quarterly earnings before interest, taxes, depreciation & amortization is -$493.52 thousand, with the most recent change of -$862.92 thousand (-233.60%) on September 30, 2024. Over the past year, it has increased by +$948.44 thousand (+65.77%). JUNS quarterly EBITDA is now -233.60% below its all-time high of $369.40 thousand, reached on June 1, 2024.JUNS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JUNS TTM EBITDA
-$1.23 M
+$948.44 K+43.58%
30 September 2024
Summary:
As of January 23, 2025, JUNS TTM earnings before interest, taxes, depreciation & amortization is -$1.23 million, with the most recent change of +$948.44 thousand (+43.58%) on September 30, 2024. Over the past year, it has increased by +$4.40 million (+78.19%). JUNS TTM EBITDA is now -154.91% below its all-time high of -$481.70 thousand, reached on September 1, 2020.JUNS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JUNS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.3% | +65.8% | +78.2% |
| 3 y3 years | -178.2% | +11.2% | +71.1% |
| 5 y5 years | -67.2% | +43.1% | +39.7% |
JUNS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.7% | at low | -233.6% | +73.0% | at high | +78.2% |
| 5 y | 5-year | -178.2% | at low | -233.6% | +73.0% | -154.9% | +78.2% |
| alltime | all time | -178.2% | at low | -233.6% | +73.0% | -154.9% | +78.2% |
Jupiter Neurosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$493.52 K(-233.6%) | -$1.23 M(-43.6%) |
| June 2024 | - | $369.40 K(-165.0%) | -$2.18 M(-34.7%) |
| Mar 2024 | - | -$568.30 K(+6.1%) | -$3.34 M(-25.3%) |
| Dec 2023 | - | -$535.47 K(-62.9%) | -$4.47 M(-20.7%) |
| Dec 2023 | -$4.57 M(+8.3%) | - | - |
| Sept 2023 | - | -$1.44 M(+82.7%) | -$5.63 M(+3.3%) |
| June 2023 | - | -$789.40 K(-53.5%) | -$5.45 M(+4.5%) |
| Mar 2023 | - | -$1.70 M(+0.0%) | -$5.21 M(+23.6%) |
| Dec 2022 | -$4.22 M | -$1.70 M(+34.8%) | -$4.22 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$1.26 M(+126.8%) | -$4.35 M(+2.4%) |
| June 2022 | - | -$555.50 K(-20.9%) | -$4.25 M(-6.8%) |
| Mar 2022 | - | -$702.70 K(-61.6%) | -$4.56 M(+11.6%) |
| Dec 2021 | -$4.09 M(+149.0%) | -$1.83 M(+58.0%) | -$4.09 M(+50.6%) |
| Sept 2021 | - | -$1.16 M(+33.6%) | -$2.71 M(+33.3%) |
| June 2021 | - | -$867.30 K(+279.1%) | -$2.04 M(+74.2%) |
| Mar 2021 | - | -$228.80 K(-50.0%) | -$1.17 M(+24.4%) |
| Dec 2020 | -$1.64 M(-39.9%) | -$457.80 K(-5.0%) | -$939.50 K(+95.0%) |
| Sept 2020 | - | -$481.70 K | -$481.70 K |
| Dec 2019 | -$2.73 M | - | - |
FAQ
- What is Jupiter Neurosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Jupiter Neurosciences?
- What is Jupiter Neurosciences annual EBITDA year-on-year change?
- What is Jupiter Neurosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Jupiter Neurosciences?
- What is Jupiter Neurosciences quarterly EBITDA year-on-year change?
- What is Jupiter Neurosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Jupiter Neurosciences?
- What is Jupiter Neurosciences TTM EBITDA year-on-year change?
What is Jupiter Neurosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of JUNS is -$4.57 M
What is the all time high annual EBITDA for Jupiter Neurosciences?
Jupiter Neurosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.64 M
What is Jupiter Neurosciences annual EBITDA year-on-year change?
Over the past year, JUNS annual earnings before interest, taxes, depreciation & amortization has changed by -$348.30 K (-8.26%)
What is Jupiter Neurosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of JUNS is -$493.52 K
What is the all time high quarterly EBITDA for Jupiter Neurosciences?
Jupiter Neurosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $369.40 K
What is Jupiter Neurosciences quarterly EBITDA year-on-year change?
Over the past year, JUNS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$948.44 K (+65.77%)
What is Jupiter Neurosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of JUNS is -$1.23 M
What is the all time high TTM EBITDA for Jupiter Neurosciences?
Jupiter Neurosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$481.70 K
What is Jupiter Neurosciences TTM EBITDA year-on-year change?
Over the past year, JUNS TTM earnings before interest, taxes, depreciation & amortization has changed by +$4.40 M (+78.19%)